Shelton Capital Management trimmed its holdings in shares of Colgate-Palmolive (NYSE:CL) by 93.1% in the first quarter, HoldingsChannel.com reports. The fund owned 2,615 shares of the company’s stock after selling 35,543 shares during the quarter. Shelton Capital Management’s holdings in Colgate-Palmolive were worth $38,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in the company. Lynch & Associates IN lifted its holdings in Colgate-Palmolive by 0.6% during the 1st quarter. Lynch & Associates IN now owns 28,930 shares of the company’s stock valued at $1,983,000 after purchasing an additional 160 shares during the last quarter. First National Bank of Omaha lifted its holdings in Colgate-Palmolive by 1.2% during the 1st quarter. First National Bank of Omaha now owns 13,499 shares of the company’s stock valued at $925,000 after purchasing an additional 160 shares during the last quarter. Griffin Asset Management Inc. lifted its holdings in Colgate-Palmolive by 0.8% during the 1st quarter. Griffin Asset Management Inc. now owns 20,357 shares of the company’s stock valued at $1,395,000 after purchasing an additional 164 shares during the last quarter. Balasa Dinverno & Foltz LLC lifted its holdings in Colgate-Palmolive by 4.7% during the 1st quarter. Balasa Dinverno & Foltz LLC now owns 3,666 shares of the company’s stock valued at $251,000 after purchasing an additional 164 shares during the last quarter. Finally, Private Capital Group LLC lifted its holdings in Colgate-Palmolive by 4.6% during the 1st quarter. Private Capital Group LLC now owns 3,801 shares of the company’s stock valued at $261,000 after purchasing an additional 168 shares during the last quarter. 75.65% of the stock is owned by institutional investors.

In other news, CEO Ian M. Cook sold 17,750 shares of Colgate-Palmolive stock in a transaction that occurred on Friday, March 29th. The shares were sold at an average price of $67.37, for a total transaction of $1,195,817.50. Following the completion of the sale, the chief executive officer now owns 1,130,793 shares in the company, valued at approximately $76,181,524.41. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Ian M. Cook sold 16,000 shares of Colgate-Palmolive stock in a transaction that occurred on Friday, March 15th. The stock was sold at an average price of $66.72, for a total transaction of $1,067,520.00. Following the sale, the chief executive officer now owns 1,146,793 shares of the company’s stock, valued at approximately $76,514,028.96. The disclosure for this sale can be found here. In the last quarter, insiders have sold 354,711 shares of company stock valued at $25,087,935. 1.14% of the stock is owned by corporate insiders.

CL opened at $71.16 on Tuesday. The company has a quick ratio of 0.74, a current ratio of 1.07 and a debt-to-equity ratio of 32.25. The stock has a market capitalization of $59.77 billion, a price-to-earnings ratio of 23.96, a P/E/G ratio of 4.56 and a beta of 0.79. Colgate-Palmolive has a 1-year low of $57.41 and a 1-year high of $73.10.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, April 26th. The company reported $0.67 earnings per share for the quarter, beating the consensus estimate of $0.66 by $0.01. Colgate-Palmolive had a net margin of 15.08% and a negative return on equity of 3,730.37%. The firm had revenue of $3.88 billion during the quarter, compared to analysts’ expectations of $3.86 billion. During the same quarter last year, the company posted $0.74 EPS. The company’s quarterly revenue was down 2.9% compared to the same quarter last year. As a group, equities research analysts forecast that Colgate-Palmolive will post 2.84 EPS for the current year.

The firm also recently declared a quarterly dividend, which was paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th were given a dividend of $0.43 per share. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.42. The ex-dividend date was Wednesday, April 17th. This represents a $1.72 annualized dividend and a dividend yield of 2.42%. Colgate-Palmolive’s payout ratio is currently 57.91%.

Several research firms have weighed in on CL. Zacks Investment Research cut shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a research report on Monday, April 29th. ValuEngine upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating in a research report on Monday, May 13th. Citigroup set a $68.00 price objective on shares of Colgate-Palmolive and gave the company a “hold” rating in a research report on Tuesday, March 19th. UBS Group raised their price objective on shares of Colgate-Palmolive from $71.00 to $75.00 and gave the company a “buy” rating in a research report on Friday, March 29th. Finally, Morgan Stanley raised their price objective on shares of Colgate-Palmolive from $62.00 to $68.00 and gave the company an “equal weight” rating in a research report on Monday, April 29th. One analyst has rated the stock with a sell rating, eleven have given a hold rating and six have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and an average price target of $69.07.

COPYRIGHT VIOLATION WARNING: This article was originally reported by Watch List News and is the sole property of of Watch List News. If you are accessing this article on another website, it was illegally copied and reposted in violation of United States and international trademark and copyright law. The legal version of this article can be read at https://www.watchlistnews.com/shelton-capital-management-has-38000-stake-in-colgate-palmolive-cl/3031259.html.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.

Featured Article: Equity Income

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.